Alveo expands avian influenza testing through Alliance

Alveo Technologies Inc., based in Alameda, California, recently announced a distribution agreement with Alliance Global to bring the Alveo Sense Poultry avian influenza test to farmers, integrators and public health officials across Africa, Central Asia and a portion of the Eastern Mediterranean.

Avian influenza has infected more than 208 million domestic birds in the United States alone since 2022 and at least 633 million globally, putting farms, supply chains and workers at serious risk. For the agricultural and public health communities in these regions, rapid on-site testing is a critical line of defense to safeguard businesses, protect flocks and reduce the risk of transmission to workers.

Under the agreement, AGBL has rights to distribute the platform across:

  • Africa
  • Central Asia
  • Select countries in the Eastern Mediterranean region

The collaboration combines Alveo’s palm-sized diagnostic technology with AGBL’s regional network and operational expertise. Together, the companies are addressing vulnerabilities in the food supply chain and delivering rapid, accurate and scalable testing solutions to support compliance, quality control and public health protection.

“AGBL’s reach across Africa, Central Asia and the Eastern Mediterranean Region gives us a direct path to farmers, integrators and health officials who need reliable avian influenza testing where outbreaks are affecting poultry producers,” said Scott Thomas, chief commercial officer at Alveo. “This agreement extends the availability of Alveo Sense Poultry to communities that depend on healthy flocks for their livelihoods and food security.”

“Farmers, public health and other officials in these regions need a way to rapidly and accurately determine whether flocks are infected with avian influenza so they can take fast action to protect other animals,” said Nassim Marie Hambouz, vice president, operations at AGBL. “We’re looking forward to providing people in these regions with access to Alveo’s revolutionary diagnostic.”

With the AGBL agreement, the Alveo Sense Poultry platform is now available globally as the company builds a regional commercial network for point-of-need avian influenza testing. For more information, visit www.alveotechnologies.com.

To contact us: hpj.com/contact/